{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-011701","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.008480+00:00","generated_at":"2026-05-20T23:48:00.773218+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lixte receives conversion notice for 350,000 Series A Preferred shares into 72,917 common shares","bullets":["Notice received May 16, 2025 for 350,000 Series A Convertible Preferred shares.","Issued to an investor in 2015 and 2016; converts into 72,917 shares of common stock.","Conversion dilutes existing common equity by approximately 72,917 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-011701","json":"https://secwatch.observer/filing/0001641172-25-011701.json","markdown":"https://secwatch.observer/filing/0001641172-25-011701.md","text":"https://secwatch.observer/filing/0001641172-25-011701.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225011701/0001641172-25-011701-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225011701/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T23:48:00.773218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}